[
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Here's an analysis of each row, following the requested format:\n\n\n**Row 1: Brazil, 2024, Diabetes**\n\nColumn Names and Values: Country: Brazil, Year: 2024, Disease Name: Diabetes, Disease Category: Genetic, Prevalence Rate (%): 0.73, Incidence Rate (%): 9.28, Mortality Rate (%): 1.09, Age Group: 19-35, Gender: Male, Population Affected: 4233, Healthcare Access (%): 54.43, Doctors per 1000: 2.58, Hospital Beds per 1000: 3.1, Treatment Type: Therapy, Average Treatment Cost (USD): 2078, Availability of Vaccines/Treatment: No, Recovery Rate (%): 61.8, DALYs: 386, Improvement in 5 Years (%): 3.23, Per Capita Income (USD): 73287, Education Index: 0.74, Urbanization Rate (%): 25.44.\n\nSentence: In Brazil in 2024, a genetic form of diabetes affected 4233 males aged 19-35, exhibiting a 0.73% prevalence, 9.28% incidence, and 1.09% mortality rate, with a 61.8% recovery rate despite the unavailability of vaccines or specific treatments costing an average of $2078, impacting 386 DALYs and showing a 3.23% improvement over five years, within a context of 54.43% healthcare access, 2.58 doctors and 3.1 hospital beds per 1000 people, a $73287 per capita income, an education index of 0.74, and a 25.44% urbanization rate.\n\nSummary:  Despite relatively high per capita income and education index, Brazil faces challenges in managing diabetes among young males due to limited treatment options and moderate healthcare access, resulting in a significant disease burden.\n\n\n**Row 2: India, 2010, Ebola**\n\nColumn Names and Values: Country: India, Year: 2010, Disease Name: Ebola, Disease Category: Genetic, Prevalence Rate (%): 4.21, Incidence Rate (%): 11.0, Mortality Rate (%): 7.01, Age Group: 0-18, Gender: Male, Population Affected: 656226, Healthcare Access (%): 73.58, Doctors per 1000: 2.35, Hospital Beds per 1000: 2.5, Treatment Type: Medication, Average Treatment Cost (USD): 27378, Availability of Vaccines/Treatment: Yes, Recovery Rate (%): 75.42, DALYs: 1953, Improvement in 5 Years (%): 4.68, Per Capita Income (USD): 44096, Education Index: 0.76, Urbanization Rate (%): 84.27.\n\nSentence: In India during 2010, a genetic form of Ebola impacted 656,226 males under 18, demonstrating a 4.21% prevalence, 11% incidence, and 7.01% mortality rate, with a 75.42% recovery rate thanks to available medication costing $27378 on average, resulting in 1953 DALYs and a 4.68% improvement over five years, within a context of 73.58% healthcare access, 2.35 doctors and 2.5 hospital beds per 1000 people, a $44096 per capita income, an education index of 0.76, and an 84.27% urbanization rate.\n\nSummary:  India in 2010 experienced a substantial Ebola outbreak among young males, yet the availability of treatment contributed to a relatively high recovery rate, despite a considerable number of DALYs.\n\n\n**Row 3: Turkey, 2003, HIV/AIDS**\n\nColumn Names and Values: Country: Turkey, Year: 2003, Disease Name: HIV/AIDS, Disease Category: Metabolic, Prevalence Rate (%): 18.56, Incidence Rate (%): 0.9, Mortality Rate (%): 7.51, Age Group: 0-18, Gender: Female, Population Affected: 751970, Healthcare Access (%): 92.95, Doctors per 1000: 0.89, Hospital Beds per 1000: 2.85, Treatment Type: Vaccination, Average Treatment Cost (USD): 25402, Availability of Vaccines/Treatment: No, Recovery Rate (%): 78.8, DALYs: 3688, Improvement in 5 Years (%): 2.15, Per Capita Income (USD): 57913, Education Index: 0.64, Urbanization Rate (%): 41.13.\n\nSentence: In Turkey during 2003, a metabolic form of HIV/AIDS affected 751,970 females under 18, showing an 18.56% prevalence, 0.9% incidence, and 7.51% mortality rate, with a 78.8% recovery rate despite the lack of vaccines or treatments costing $25402 on average, resulting in 3688 DALYs and a 2.15% improvement over five years, within a context of 92.95% healthcare access, 0.89 doctors and 2.85 hospital beds per 1000 people, a $57913 per capita income, an education index of 0.64, and a 41.13% urbanization rate.\n\nSummary: Turkey in 2003 faced a high prevalence of HIV/AIDS among young girls, highlighting the need for effective treatments despite high healthcare access and per capita income.  The lack of vaccines/treatments is a significant factor.\n\n\n**Row 4: India, 2017, Polio**\n\nColumn Names and Values: Country: India, Year: 2017, Disease Name: Polio, Disease Category: Cardiovascular, Prevalence Rate (%): 1.26, Incidence Rate (%): 6.79, Mortality Rate (%): 7.42, Age Group: 36-60, Gender: Other, Population Affected: 243846, Healthcare Access (%): 50.4, Doctors per 1000: 2.08, Hospital Beds per 1000: 5.39, Treatment Type: Medication, Average Treatment Cost (USD): 9681, Availability of Vaccines/Treatment: No, Recovery Rate (%): 60.5, DALYs: 4084, Improvement in 5 Years (%): 6.72, Per Capita Income (USD): 56210, Education Index: 0.56, Urbanization Rate (%): 78.17.\n\nSentence: In India in 2017, a cardiovascular form of Polio affected 243,846 individuals aged 36-60 of unspecified gender, presenting a 1.26% prevalence, 6.79% incidence, and 7.42% mortality rate, with a 60.5% recovery rate, despite lacking vaccines or treatments, costing $9681 on average, resulting in 4084 DALYs and a 6.72% improvement over five years, within a context of 50.4% healthcare access, 2.08 doctors and 5.39 hospital beds per 1000 people, a $56210 per capita income, an education index of 0.56, and a 78.17% urbanization rate.\n\nSummary: India in 2017 showed a notable burden of Polio among the 36-60 age group, despite a moderate per capita income, indicating challenges related to healthcare access and treatment availability.\n\n\n**Row 5: Turkey, 2009, Parkinson's Disease**\n\nColumn Names and Values: Country: Turkey, Year: 2009, Disease Name: Parkinson's Disease, Disease Category: Parasitic, Prevalence Rate (%): 0.13, Incidence Rate (%): 4.88, Mortality Rate (%): 5.56, Age Group: 36-60, Gender: Other, Population Affected: 928625, Healthcare Access (%): 77.83, Doctors per 1000: 1.09, Hospital Beds per 1000: 7.68, Treatment Type: Surgery, Average Treatment Cost (USD): 16925, Availability of Vaccines/Treatment: No, Recovery Rate (%): 92.6, DALYs: 1011, Improvement in 5 Years (%): 9.73, Per Capita Income (USD): 4928, Education Index: 0.56, Urbanization Rate (%): 21.46.\n\nSentence: In Turkey in 2009, a parasitic form of Parkinson's disease affected 928,625 individuals aged 36-60 of unspecified gender, exhibiting a 0.13% prevalence, 4.88% incidence, and 5.56% mortality rate, with a high 92.6% recovery rate despite the lack of vaccines or specific treatments (surgery was used), costing $16925 on average, resulting in 1011 DALYs and a significant 9.73% improvement over five years, within a context of 77.83% healthcare access, 1.09 doctors and 7.68 hospital beds per 1000 people, a $4928 per capita income, an education index of 0.56, and a 21.46% urbanization rate.\n\nSummary:  Turkey in 2009 showed a surprisingly high recovery rate for Parkinson's disease, despite a low per capita income and the absence of specific vaccines or treatments.  The high number of hospital beds may be a contributing factor."
    }
]